A forward genetic screen identifies Sirtuin1 as a driver of neuroendocrine prostate cancer
Francisca Nunes de Almeida, Alessandro Vasciaveo, Arianna Giacobbe, Matteo Di Bernardo, Min Zou, Ainsley Mike Antao, Simone de Brot, Antonio Rodríguez-Calero, Alexander Chui, Alexander L.E. Wang, Nicolas Floc’h, Jaime Y. Kim, Soonbum Park, Stephanie N. Afari, Timur Mukhammadov, , Cory T. Abate-Shen
The paper uses a forward genetic screen in a mouse model to identify Sirtuin1 as a driver of neuroendocrine prostate cancer, showing its role in promoting NEPC and potential as a therapeutic target.
The Journal of Experimental Medicine · Apr 28, 2026Peer-reviewedCancer Biology